Table: begin end state 1 22 cytoplasmic 23 41 transmembrane 42 60 non-cytoplasmic 61 80 transmembrane 81 91 cytoplasmic 92 110 transmembrane 111 115 non-cytoplasmic 116 138 transmembrane 139 149 cytoplasmic 150 173 transmembrane 174 184 non-cytoplasmic 185 207 transmembrane 208 249 cytoplasmic 250 271 transmembrane 272 285 non-cytoplasmic 286 304 transmembrane 305 315 cytoplasmic 316 334 transmembrane 335 339 non-cytoplasmic 340 362 transmembrane 363 373 cytoplasmic 374 395 transmembrane 396 406 non-cytoplasmic 407 424 transmembrane 425 434 cytoplasmic
Input: >Pf6N2E2_1312 MSTAHTANTAGTVAHDRTHATITWRLMPLLLVCYLFAHLDRINIGFAKMQMSADLQFSDT VYGFGAGLFFIAYALFGVPSNMALDRVGPRRWIATLMVVWGALSSGMFLIDSAAGFYVLR FLLGVAEAGFFPGILVFLNRWYPARRRAQVTALFAIAVPMAGVIGGPLSGGILEHFHDVG GLRGWQWMFVIEGLPVILLGLVVLKCLPDDFETVKWLTPHAKQQLREQLSLEEQRKSITS FSAILNNPQVWLLVAVYFAVMLAVNTLAFWMPTLIHGAGIGSDGKVGLLSAVPYLAGCFF MIGCGRSSDRHRERRWHLCVPLLMAALGIAVTGLSPGNPILVLSGLIVAGMGASAALPMF WQLPPAFLSNGTQAAGIALISSFGSIASFFAPYLIGWMRDTTQSASLALYALALLIALGG LLVLRTHAAIVNPQ
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server